OLEMA PHARMACEUTICALS, INC. Earnings Per Share (Basic)
OLEMA PHARMACEUTICALS, INC. (OLMA) reported Earnings Per Share (Basic) of -$0.61 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-10
- OLEMA PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.61.
- OLEMA PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.52.
- OLEMA PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.49.
- OLEMA PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.51.
- OLEMA PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2025 was -$1.87.
- OLEMA PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2024 was -$2.20.
- OLEMA PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2023 was -$2.14.
- OLEMA PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2022 was -$2.62.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.61 10-Q · filed 2026-08-10 | -$1.12 10-Q · filed 2026-08-10 | ||
| 2026-03-31 | -$0.52 10-Q · filed 2026-05-12 | |||
| 2025-12-31 | -$1.87 10-K · filed 2026-03-16 | |||
| 2025-09-30 | -$0.49 10-Q · filed 2025-11-10 | -$1.36 10-Q · filed 2025-11-10 | ||
| 2025-06-30 | -$0.51 10-Q · filed 2026-08-10 | -$0.87 10-Q · filed 2026-08-10 | ||
| 2025-03-31 | -$0.36 10-Q · filed 2026-05-12 | |||
| 2024-12-31 | -$2.20 10-K · filed 2026-03-16 | |||
| 2024-09-30 | -$0.60 10-Q · filed 2025-11-10 | -$1.80 10-Q · filed 2025-11-10 | ||
| 2024-06-30 | -$0.54 10-Q · filed 2025-08-11 | -$1.10 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | -$0.56 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | -$2.14 10-K · filed 2025-03-18 | |||
| 2023-09-30 | -$0.48 10-Q · filed 2024-11-12 | -$1.66 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | -$0.49 10-Q · filed 2024-08-06 | -$1.20 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | -$0.70 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | -$2.62 10-K · filed 2024-03-11 | |||
| 2022-09-30 | -$0.57 10-Q · filed 2023-11-07 | -$1.97 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | -$0.82 10-Q · filed 2023-08-08 | -$1.40 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | -$0.58 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | -$0.54 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$0.99 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$1.80 10-K · filed 2023-03-09 | |
| 2021-09-30 | -$0.45 10-Q · filed 2022-11-08 | -$1.25 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | -$0.42 10-Q · filed 2022-08-09 | -$0.81 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | -$0.39 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | -$0.50 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$1.74 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$3.42 10-K · filed 2022-02-28 | |
| 2020-09-30 | -$3.71 10-Q · filed 2021-11-10 | -$5.29 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | -$0.95 10-Q · filed 2021-08-10 | -$1.60 10-Q · filed 2021-08-10 | ||
| 2019-12-31 | -$1.66 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |